Learn about how different healthcare providers work together to help breast cancer patients weigh their treatment options.
The approval follows the December 2024 priority review designation for this perioperative immunotherapy regimen for patients fighting muscle-invasive bladder cancer.
First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.
The FDA has approved Imfinzi® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with MIBC.
The Miami-based company isn't alone in making that bet. Gannon University and Saint Vincent Hospital announced plans Wednesday to develop two new laboratories inside Gannon's Institute for ...
Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.
Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...
NICE has rejected Pfizer’s Ibrance breast cancer drug in first draft guidance, citing the treatment's high cost. The decision confirms the company’s fears that the drug would fare badly under ...
Research studies explore the different factors that affect health and lead to disease. Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ...
Itovebi, combined with Ibrance and Faslodex, is approved for specific advanced breast cancer cases with PIK3CA mutations. The INAVO120 trial showed Itovebi significantly improved progression-free ...
According to the World Health Organization (WHO), breast cancer was the most common cancer in women in 157 countries out of 185 in 2022, with incidence rates found to be rising by 1% per year overall ...
There are figures that leave no room for doubt, and this is one of them: over 600 million people worldwide suffer from low back pain. And the situation is only going to worsen. It is estimated that by ...